Related Experiment Video

Updated: Dec 29, 2025

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
11:01

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

Published on: August 30, 2011

14.0K

Rescuing Research Participants After Alzheimer Trials Stop Early: Sending Out an SOS

Emily A Largent1, Jason Karlawish2

  • 1Perelman School of Medicine, Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia.

JAMA Neurology
|February 4, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.0K
Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
07:01

Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment

Published on: September 20, 2020

5.1K

Related Experiment Videos

Last Updated: Dec 29, 2025

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
11:01

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

Published on: August 30, 2011

14.0K
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

18.0K
Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
07:01

Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment

Published on: September 20, 2020

5.1K

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

702
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
702

Articles linked to this work by shared authors, journal, and citation graph.

CONNECT4 APOE: A randomized trial of telephone versus real-time two-way videoconference for disclosure of APOE genotype results in cognitively unimpaired adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Legal Protections to Mitigate Discrimination due to Neurodegenerative Biomarker Status.

Neurology·2026

Study of the utility and impact of a plasma p-tau181 Alzheimer's biomarker (SUITABLE).

Alzheimer's & dementia (New York, N. Y.)·2026

Designing Consent Processes for Research With Older Adults Who May Lack Decisional Capacity: A Guide for Investigators.

Journal of the American Geriatrics Society·2026

Four Common Beliefs About Patient Memory Evaluations: Who Has Them and What Modifies Them?

American journal of Alzheimer's disease and other dementias·2026

Expert consensus on communicating tau PET results to persons living with MCI or dementia: Findings from a modified Delphi study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

When to Use the HINTS Examination in Patients With Dizziness: A Review.

JAMA neurology·2026

A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease.

JAMA neurology·2026

Intravenous Immunoglobulin Add-On in Newly Diagnosed Idiopathic Inflammatory Myopathies: A Randomized Clinical Trial.

JAMA neurology·2026

Clinical Characteristics, Neuroimaging Findings, and Mortality in Korsakoff Syndrome.

JAMA neurology·2026

Common MC1R Variants and Parkinson Disease Progression.

JAMA neurology·2026

Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease.

JAMA neurology·2026

Characterization of spurious-electron signals in the double-phase argon TPC of the DarkSide-50 experiment.

The European physical journal. C, Particles and fields·2026

Experimental validation of ambient dose equivalent rate calculations for a 241Am-Be neutron source using OpenMC code.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026

Evaluation of neutron dose equivalent in prostate stereotactic body radiotherapy by bubble detector.

Biomedical physics & engineering express·2026

Emission of fast ions in Penning ionization.

The Journal of chemical physics·2026

Dosimetric evaluation of systematic source position uncertainty along the source path and robust planning during MRI-only cervical HDR brachytherapy.

Journal of applied clinical medical physics·2026

The next-generation magnetic recoil spectrometer for measurements of the absolute neutron spectrum at Pacific Fusion's demonstration system.

The Review of scientific instruments·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us